Despite 10 Percent Decline in Q1 Revenues, Waters CEO Sees Rays of Light for Second Half of 2009

Sustained interest in its high-end mass specs as well as the Acquity UPLC, along with stimulus-fund spending, fueled cautious optimism from CEO Douglas Berthiaume that the worst may have passed.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.